Results 161 to 170 of about 3,834 (193)
Some of the next articles are maybe not open access.

[Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].

Nihon rinsho. Japanese journal of clinical medicine, 1999
Vancomycin-resistant MRSA (VRSA with MIC > or = 8 mg/L) has been described, recently. Although the incidence of VRSA has been low in Japanese MRSA strains, hetero-VRSA (heterogeneously resistant VRSA with MIC levels of 2-4 mg/L) is found in considerable abundance in Japanese hospitals, that may explain fairly frequent therapeutic failure in the ...
Y, Inaba, K, Hiramatsu
openaire   +1 more source

Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA)

International Journal of Antimicrobial Agents, 2013
Around the world, Staphylococcus aureus remains a dominant cause of bacteraemia. Whilst meticillin resistance remains the major phenotype of concern, various levels of reduced glycopeptide susceptibility are emerging with increasing frequency. The most common MRSA phenotypes now have raised vancomycin MICs within the susceptible range (MICs of 1-2mg/L).
openaire   +2 more sources

Isolation and characterization of six gamma-irradiated bacteriophages specific for MRSA and VRSA isolated from skin infections

Journal of Radiation Research and Applied Sciences, 2021
Maha Abo-Shadi, Omnia Karem M Riad
exaly  

BRIEF REVIEW ON MRSA AND VRSA

World Journal of Pharmaceutical Research, 2017
openaire   +1 more source

ZnO nanoparticles inhibit growth and biofilm formation of vancomycin-resistant S. aureus (VRSA)

Biocatalysis and Agricultural Biotechnology, 2020
Hussein A Abid, Ahmed Mahdi Rheima
exaly  

Home - About - Disclaimer - Privacy